A company-initiated recall of two models of EMBLEM S-ICD (Boston Scientific) subcutaneous implantable cardioverter defibrillator pulse generators has been categorized as Class I by the US Food and Drug Administration (FDA), the agency announced today. The FDA notes that the advisory, which was communicated to patients and doctors in December, applies to 2825 of the